The middle east respiratory syndrome coronavirus – a continuing risk to global health security

Advances in Experimental Medicine and Biology

Volumn 972, Issue , 2017, Pages 49-60

  Azhar, Esam I ^a   Lanini, Simone ^b   Ippolito, Giuseppe ^b   Zumla, Alimuddin ^c,d  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Camels; Coronavirus; Drugs; Infection control; MERS; MERS CoV; Middle East; Risk; Treatment

Indexed keywords

ALISPORIVIR; ALPHA INTERFERON; BETA INTERFERON; CHLOROQUINE; CYCLOSPORIN A; DNA VACCINE; INTERFERON; LOPINAVIR; MYCOPHENOLIC ACID; NELFINAVIR; NITAZOXANIDE; RIBAVIRIN; SMALL INTERFERING RNA;

CLINICAL FEATURE; DISEASE SURVEILLANCE; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION CONTROL; LABORATORY DIAGNOSIS; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOLECULAR EVOLUTION; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; VIRUS GENOME; VIRUS TRANSMISSION; ADOLESCENT; ADULT; AGED; ANIMAL; CHILD; CLASSIFICATION; CORONAVIRUS INFECTIONS; FEMALE; GLOBAL HEALTH; INFANT; MALE; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; RISK FACTOR; TIME FACTOR; TRANSMISSION; VERY ELDERLY; VIROLOGY; YOUNG ADULT; ZOONOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CHILD; CHILD, PRESCHOOL; CORONAVIRUS INFECTIONS; FEMALE; GLOBAL HEALTH; HUMANS; INFANT; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RISK FACTORS; TIME FACTORS; YOUNG ADULT; ZOONOSES;

EID: 85019437847     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/5584_2016_133     Document Type: Chapter

References (76)

1. Al-Abdallat MM, Payne DC, Alqasrawi S (2014) Jordan MERS-CoV investigation team. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis 59:1225-1233
2. Al-Tawfiq JA, Zumla A, Gautret P, Gray GC, Hui DS, Al-Rabeeah AA, Memish ZA (2014a) Surveillance for emerging respiratory viruses. Lancet Infect Dis 14(10):992-1000
3. Al-Tawfiq JA, Zumla A, Memish ZA (2014b) Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers. Curr Opin Infect Dis 27(5):411-417
4. Annan A, Baldwin HJ, Corman VM et al (2013) Human betacoronavirus 2c EMC/2012-related viruses in bats. Ghana and Europe Emerg Infect Dis 19:456-459
5. Assiri A, McGeer A, Perl TM (2013a) et al; KSA MERS-CoV investigation team. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 369:407-416
6. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF, Makhdoom HQ, Zumla A, Memish ZA (2013b) Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 13(9):752-761
7. Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM et al (2014) Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 370(26):2499-2505
8. Balkhy HH, Alenazi TH, Alshamrani MM, Baffoe-Bonnie H, Al-Abdely HM, El-Saed A, Al Arbash HA, Al Mayahi ZK, Assiri AM, Bin Saeed A (2016) Notes from the field: nosocomial outbreak of Middle East respiratory syndrome in a large tertiary care hospital-Riyadh, Saudi Arabia, 2015. MMWR Morb Mortal Wkly Rep 65(6):163-164. doi:10.15585/mmwr.mm6506a5
9. CDC (2016) Middle East Respiratory Syndrome (MERS). http://www.cdc.gov/coronavirus/mers/. Accessed 28 Feb 2016
10. Chan JF, Chan KH, Kao RY et al (2013) Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect 67:606-616
11. Corman VM, Muller MA, Costabel U, Timm J, Binger T, Meyer B et al (2012) Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill 17:20334. [PubMed]PubMed
12. Corman VM, Ithete NL, Richards LR, Schoeman MC, Preiser W, Drosten C et al (2014) Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat. J Virol 88:11297-11303. doi:10.1128/JVI.01498-14[PMCfreearticle][PubMed][CrossRef]
13. Cotten M, Watson SJ, Kellam P, Al-Rabeeah AA, Makhdoom HQ, Assiri A, Al-Tawfiq JA, Alhakeem RF, Madani H, AlRabiah FA, Al Hajjar S, Al-nassir WN, Albarrak A, Flemban H, Balkhy HH, Alsubaie S, Palser AL, Gall A, Bashford-Rogers R, Rambaut A, Zumla AI, Memish ZA (2013a) Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet 382(9909):1993-2002
14. Cotten M, Watson SJ, Kellam P, Al-Rabeeah AA, Makhdoom HQ, Assiri A et al (2013b) Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet 382:1993-2002
15. Cotten M, Watson SJ, Zumla AI, Makhdoom HQ, Palser AL, Ong SH, Al Rabeeah AA, Alhakeem RF, Assiri A, Al-Tawfiq JA, Albarrak A, Barry M, Shibl A, Alrabiah FA, Hajjar S, Balkhy HH, Flemban H, Rambaut A, Kellam P, Memish ZA (2014) Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. mBio 5(1):e01062
16. de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, Fouchier RA, Galiano M, Gorbalenya AE, Memish ZA, Perlman S, Poon LL, Snijder EJ, Stephens GM, Woo PC, Zaki AM, Zambon M, Ziebuhr J (2013) Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the coronavirus study group. J Virol 87(14):7790-7792
17. de Wilde AH, Raj VS, Oudshoorn D et al (2013) MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment. J Gen Virol 94:1749-1760
18. Du L, Han GZ (2016) Deciphering MERS-CoV evolution in dromedary camels. Trends Microbiol 24(2):87-89. doi:10.1016/j.tim.2015.12.013. Epub 2016 Jan 8
19. Falzarano D, de Wit E, Martellaro C et al (2013a) Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin. Sci Rep 3:1686
20. Falzarano D, de Wit E, Rasmussen AL et al (2013b) Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med 19:1313-1317
21. Gossner C, Danielson N, Gervelmeyer A, Berthe F, Faye B, Kaasik Aaslav K, Adlhoch C, Zeller H, Penttinen P, Coulombier D (2016) Human-dromedary camel interactions and the risk of acquiring zoonotic Middle East respiratory syndrome coronavirus infection. Zoonoses Public Health 63(1):1-9
22. Haagmans BL, Al Dhahiry SH, Reusken CB et al (2014) Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis 14:140-145
23. Hemida MG, Perera RA, Al Jassim RA et al (2014) Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill 19:20828
24. Hijawi B, Abdallat M, Sayaydeh A et al (2013) Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J 19(Suppl 1):S12-S18
25. Hui DS, Zumla A (2014) Advancing priority research on the Middle East respiratory syndrome coronavirus. J Infect Dis 209:173-176
26. Hui DS, Zumla A (2015) Emerging respiratory tract viral infections. Curr Opin Pulm Med 21(3):284-292
27. Hui DS, Perlman S, Zumla A (2015a) Spread of MERS to South Korea and China. Lancet Respir Med. pii: S2213-2600(15)00238-6. doi:10.1016/S2213-2600(15)00238-6. [Epub ahead of print]
28. Hui DS, Perlman S, Zumla A (2015a) Spread of MERS to South Korea and China. Lancet Respir Med 3(7):509-510
29. ISARIC and Public Health England (2014) Treatment of MERS-CoV: information for clinicians. Clinical decision-making support for treatment of MERS-CoV patients v2.0 14 July 2014. Available at https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/360424/MERS_COV_information_for_clinicians_17_July.pdf
30. Kim YJ, Cho YJ, Kim DW, Kim H, Park S et al (2015) Complete genome sequence of Middle East respiratory syndrome coronavirus KOR/KNIH/002_05_2015, isolated in South Korea. Genome Announc 3:e00787-15. [PMC free article] [PubMed]
31. Kim Y, Cheon S, Min CK, Sohn KM, Kang YJ, Cha YJ, Kang JI, Han SK, Ha NY, Kim G, Aigerim A, Shin HM, Choi MS, Kim S, Cho HS, Kim YS, Cho NH. Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak. MBio. 2016 Mar 1;7(2):e00019. doi:10.1128/mBio.00019-16.PMID:26933050.
32. Kim JI, Kim YJ, Lemey P, Lee I, Park S, Bae JY, Kim D, Kim H, Jang SI, Yang JS, Kim H, Kim DW, Nam JG, Kim SS, Kim K, Myun Lee J, Song MK, Song D, Chang J, Hong KJ, Bae YS, Song JW, Lee JS, Park MS (2016b) The recent ancestry of Middle East respiratory syndrome coronavirus in Korea has been shaped by recombination. Sci Rep 6:18825
33. Lessler J, Rodriguez-Barraquer I, Cummings DA, Garske T, Van Kerkhove M, Mills H, Truelove S, Hakeem R, Albarrak A, Ferguson NM (2014) MERS-CoV Scenario Modeling Working Group. Estimating potential incidence of MERS-CoV associated with Hajj Pilgrims to Saudi Arabia. PLoS Curr 6. pii: ecurrents. outbreaks. c5c9c9abd636164a9b6fd4dbda974369
34. Lessler J, Salje H, Van Kerkhove MD, Ferguson NM, Cauchemez S, Rodriquez-Barraquer I, Hakeem R, Jombart T, Aguas R, Al-Barrak A, Cummings DA (2016) MERS-CoV Scenario and Modeling Working Group. Estimating the severity and subclinical burden of Middle East respiratory syndrome coronavirus infection in the Kingdom of Saudi Arabia. Am J Epidemiol. pii: kwv452. [Epub ahead of print]
35. Lu G, Hu Y, Wang Q, Qi J, Gao F, Li Y, Zhang Y, Zhang W, Yuan Y, Bao J, Zhang B, Shi Y, Yan J, Gao GF (2013) Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 500(7461):227-231
36. McCloskey B, Dar O, Zumla A, Heymann DL (2014) Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread. Lancet Infect Dis 14(10):1001-1010
37. Memish ZA, Zumla AI, Al-Hakeem RF et al (2013a) Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 368:2487-2494
38. Memish ZA, Zumla A, Assiri A (2013b) Middle East respiratory syndrome coronavirus infections in health care workers. N Engl J Med 369(9):884-886
39. Memish ZA, Mishra N, Olival KJ et al (2013c) Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 19:1819-1823
40. Memish ZA, Zumla A, Alhakeem RF, Assiri A, Turkestani A, Al Harby KD, Alyemni M, Dhafar K, Gautret P, Barbeschi M, McCloskey B, Heymann D, Al Rabeeah AA, Al-Tawfiq JA (2014a) Hajj: infectious disease surveillance and control. Lancet 383(9934):2073-2082
41. Memish ZA, Zumla A, McCloskey B, Heymann D, Al Rabeeah AA, Barbeschi M, Horton R (2014b) Mass gatherings medicine: international cooperation and progress. Lancet 383(9934):2030-2032
42. MERS CDC Laboratory testing for MERS-CoV (2016) http://www.cdc.gov/coronavirus/MERS/lab/lab-testing.html. Accessed 24 Feb 2016
43. Meyer B, Muller MA, Corman VM et al (2014) Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis 20:552-559
44. Muller MA, Corman VM, Jores J et al (2014) MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerg Infect Dis 20:2093-2095
45. Muthumani K, Falzarano D, Reuschel EL, Tingey C, Flingai S, Villarreal DO, Wise M, Patel A, Izmirly A, Aljuaid A, Seliga AM, Soule G, Morrow M, Kraynyak KA, Khan AS, Scott DP, Feldmann F, LaCasse R, Meade-White K, Okumura A, Ugen KE, Sardesai NY, Kim JJ, Kobinger G, Feldmann H, Weiner DB (2015) A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates. Sci Transl Med 7(301):301ra132
46. Oboho IK, Tomczyk SM, Al-Asmari AM et al (2015) 2014 MERS-CoV outbreak in Jeddah-A link to health care facilities. N Engl J Med 372:846-854
47. Omrani AS, Saad MM, Baig K et al (2014) Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis 14:1090-1095
48. Park SW, Perera RA, Choe PG, Lau EH, Choi SJ, Chun JY, Oh HS, Song KH, Bang JH, Kim ES, Kim HB, Park WB, Kim NJ, Poon LL, Peiris M, Oh MD (2015) Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection. Euro Surveill 15:20(41). doi:10.2807/1560-7917
49. Peiris JS, Yuen KY, Osterhaus AD, Stohr K (2003) The severe acute respiratory syndrome. N Engl J Med 349:2431-2441
50. Penttinen PM, Kaasik-Aaslav K, Friaux A et al (2013) Taking stock of the first 133 MERS coronavirus cases globally-Is the epidemic changing? Euro Surveill 18(39):20596
51. Petersen E, Hui DS, Perlman S, Zumla A (2015) Middle East respiratory syndrome-advancing the public health and research agenda on MERS-lessons from the South Korea outbreak. Int J Infect Dis 36:54-55
52. Petersen E, Wilson ME, Touch S, McCloskey B, Mwaba P, Bates M, Dar O, Mattes F, Kidd M, Ippolito G, Azhar EI, Zumla A (2016) Rapid spread of Zika virus in the Americas-implications for public health preparedness for mass gatherings at the 2016 Brazil Olympic Games. Int J Infect Dis 44:11-15
53. Rabozzi G, Bonizzi L, Crespi E, Somaruga C, Sokooti M, Tabibi R, Vellere F, Brambilla G, Colosio C (2012) Emerging zoonoses: the “one health approach”. Saf Health Work 3(1):77-83
54. Reusken CB, Haagmans BL, Müller MA et al (2013) Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis 13:859-866
55. Reusken CB, Messadi L, Feyisa A et al (2014) Geographic distribution of MERS coronavirus among dromedary camels, Africa. Emerg Infect Dis 20:1370-1374
56. Sabir JS, Lam TT, Ahmed MM, Li L, Shen Y, Abo-Aba SE, Qureshi MI, Abu-Zeid M, Zhang Y, Khiyami MA, Alharbi NS, Hajrah NH, Sabir MJ, Mutwakil MH, Kabli SA, Alsulaimany FA, Obaid AY, Zhou B, Smith DK, Holmes EC, Zhu H, Guan Y (2016) Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science 351(6268):81-84
57. Shalhoub S, Farahat F, Al-Jiffri A et al (2015) IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study. J Antimicrob Chemother 70:2129-2132
58. Soliman T, Cook AR, Coker RJ (2015) Pilgrims and MERS-CoV: what’s the risk? Emerg Themes Epidemiol 12:3
59. The WHO MERS-CoV Research Group (2013) State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans. PLoS Curr 5. pii: ecurrents. outbreaks.0bf719e352e7478f8ad85fa30127ddb8
60. Waldron G, Doherty L (2015) Low public health risk of MERS-CoV in people returning from the Hajj. BMJ 351:h5543
61. Wang Y, Liu D, Shi W, Lu R, Wang W, Zhao Y et al (2015) Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis. MBio 6:e01280-15. doi:10.1128/mBio.01280-15[PMCfreearticle][PubMed][CrossRef
62. WHO (2015a) Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected. Interim guidance. Updated 2 July 2015. Accessed 28 Feb 2016. Available at http://www.who.int/csr/disease/coronavirus_infections/case-management-ipc/en/
63. WHO (2015b) Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected. Interim guidance. Updated 2 July 2015WHO/MERS/Clinical/15.1. http://apps.who.int/iris/bitstream/10665/178529/1/WHO_MERS_Clinical_15.1_eng.pdf?ua=1
64. WHO (2015c) Outbreaks and emergencies Middle East respiratory syndrome coronavirus (MERS-CoV) MERS-CoV in Republic of Korea at a glance Accessed 28 Nov 2016 Available at http://www.wpro.who.int/outbreaks_emergencies/wpro_coronavirus/en/
65. WHO (2016) Middle East respiratory syndrome coronavirus (MERS-CoV)-update. Disease outbreak news. Accessed 28 November 2016. Available at: http://www.who.int/emergencies/mers-cov/en/
66. Younan M, Bornstein S, Gluecks IV. MERS and the dromedary camel trade between Africa and the Middle East. Trop Anim Health Prod. 2016 Aug;48(6):1277-82. doi:10.1007/s11250-016-1089-3.PubMedPMID:27324244.
67. Yu IT, Qiu H, Tse LA, Wong TW (2014) Severe acute respiratory syndrome beyond Amoy Gardens: completing the incomplete legacy. Clin Infect Dis 58:683-686
68. Zaki AM, van Boheemen S, Bestebroer TM et al (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814-1820
69. Zumla A, Hui DS (2014) Infection control and MERS-CoV in health-care workers. Lancet 383(9932):1869-1871
70. Zumla A, Memish ZA, Maeurer M, Bates M, Mwaba P, Al-Tawfiq JA, Denning DW, Hayden FG, Hui DS (2014) Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options. Lancet Infect Dis 14(11):1136-1149
71. Zumla A, Hui DS, Perlman S (2015a) State of the ART Seminar: Middle East respiratory syndrome. The Lancet. pii: S0140-6736(15)60454-8. [Epub ahead of print]
72. Zumla A, Azhar EI, Arabi Y, Alotaibi B, Rao M, McCloskey B, Petersen E, Maeurer M (2015b) Host-directed therapies for improving poor treatment outcomes associated with the Middle East respiratory syndrome coronavirus infections. Int J Infect Dis. pii: S1201-9712(15)00215-5
73. Zumla A, Perlman S, McNabb SJ, Shaikh A, Heymann DL, McCloskey B, Hui DS (2015c) Middle East respiratory syndrome in the shadow of Ebola. Lancet Resp Med 3(2):100-102
74. Zumla A, Rustomjee R, Ntoumi F, Mwaba P, Bates M, Maeurer M, Hui DS, Petersen E (2015d) Middle East respiratory syndrome--need for increased vigilance and watchful surveillance for MERS-CoV in sub-Saharan Africa. Int J Infect Dis 37:77-79
75. Zumla A, Heymann D, Ippolito G (2015e) Be prepared: Europe needs Ebola outbreak consortium. Nature 523(7558):35. doi:10.1038/523035b
76. Zumla A, Chan J, Azhar EI, Hui D, Yuen KY (2016) Coronaviruses-drug discovery and therapeutic options. Nat Rev Drug Discov. doi:10.1038/nrd.2015.37. [Epub ahead of print]